DE60139694D1 - Menschliche myelom zelllinie - Google Patents

Menschliche myelom zelllinie

Info

Publication number
DE60139694D1
DE60139694D1 DE60139694T DE60139694T DE60139694D1 DE 60139694 D1 DE60139694 D1 DE 60139694D1 DE 60139694 T DE60139694 T DE 60139694T DE 60139694 T DE60139694 T DE 60139694T DE 60139694 D1 DE60139694 D1 DE 60139694D1
Authority
DE
Germany
Prior art keywords
myeloma cell
cell line
human myeloma
human
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60139694T
Other languages
German (de)
English (en)
Inventor
Abraham Karpas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016824A external-priority patent/GB0016824D0/en
Priority claimed from GB0017139A external-priority patent/GB0017139D0/en
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Application granted granted Critical
Publication of DE60139694D1 publication Critical patent/DE60139694D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60139694T 2000-07-07 2001-07-09 Menschliche myelom zelllinie Expired - Fee Related DE60139694D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0016824A GB0016824D0 (en) 2000-07-07 2000-07-07 Human monoclonal antibodies
GB0017139A GB0017139D0 (en) 2000-07-12 2000-07-12 Human monoclonal antibodies
US27058801P 2001-02-23 2001-02-23
PCT/GB2001/003059 WO2002004607A1 (en) 2000-07-07 2001-07-09 Human myeloma cell line

Publications (1)

Publication Number Publication Date
DE60139694D1 true DE60139694D1 (de) 2009-10-08

Family

ID=27255800

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139694T Expired - Fee Related DE60139694D1 (de) 2000-07-07 2001-07-09 Menschliche myelom zelllinie

Country Status (12)

Country Link
US (1) US7387873B2 (enExample)
EP (1) EP1299524B1 (enExample)
JP (1) JP2004502454A (enExample)
KR (1) KR20030022850A (enExample)
CN (1) CN100497601C (enExample)
AT (1) ATE440945T1 (enExample)
AU (2) AU2001269300B2 (enExample)
CA (1) CA2415484A1 (enExample)
DE (1) DE60139694D1 (enExample)
IL (1) IL153641A0 (enExample)
NO (1) NO20030019L (enExample)
WO (1) WO2002004607A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502454A (ja) 2000-07-07 2004-01-29 ケンブリッジ・ユニヴァーシティ・テクニカル・サーヴィシズ・リミテッド ヒト骨髄腫細胞系
AU2002357932A1 (en) 2001-12-18 2003-06-30 Whitehead Institute For Biomedical Research Fusion partner cells and uses thereof
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8460745B2 (en) * 2009-09-20 2013-06-11 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US20110070358A1 (en) * 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
CN105601734A (zh) * 2016-03-01 2016-05-25 广东医学院附属医院 一种从人外周血记忆性b淋巴细胞制备抗体的方法
CN115161311B (zh) * 2022-08-22 2025-05-06 广东忠信生物科技有限公司 高效筛选分泌单克隆抗体的杂交瘤细胞的方法及其应用
CN115463146B (zh) * 2022-10-14 2024-01-23 浙大城市学院 哇巴因化合物作为在制备抗病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379055D1 (en) * 1982-06-09 1989-03-02 Asahi Chemical Ind Method for producing human antibody
US4720459A (en) * 1985-02-14 1988-01-19 Medical College Of Wisconsin Research Foundation, Inc. Myelomas for producing human/human hybridomas
JP2004502454A (ja) 2000-07-07 2004-01-29 ケンブリッジ・ユニヴァーシティ・テクニカル・サーヴィシズ・リミテッド ヒト骨髄腫細胞系

Also Published As

Publication number Publication date
CA2415484A1 (en) 2002-01-17
IL153641A0 (en) 2003-07-06
AU6930001A (en) 2002-01-21
CN1455813A (zh) 2003-11-12
ATE440945T1 (de) 2009-09-15
US20040023339A1 (en) 2004-02-05
KR20030022850A (ko) 2003-03-17
US7387873B2 (en) 2008-06-17
CN100497601C (zh) 2009-06-10
EP1299524B1 (en) 2009-08-26
WO2002004607A1 (en) 2002-01-17
JP2004502454A (ja) 2004-01-29
AU2001269300B2 (en) 2006-06-22
NO20030019D0 (no) 2003-01-03
EP1299524A1 (en) 2003-04-09
NO20030019L (no) 2003-03-07

Similar Documents

Publication Publication Date Title
TR200300478T2 (tr) Hümanize antiLT-ß-R antikorları
BR0209766B1 (pt) cÉlula combustÍvel com meios de gerenciar a hidrataÇço.
DE60115785D1 (de) Mit Wasserstoffverbrennung betriebene Heizungsanlage
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
DK1478667T3 (da) Monoklonalt anti-humant tenascin-antistof
DK1308507T3 (da) Monoklonalt antistof mod HCV-kerneantigen
ATE440945T1 (de) Menschliche myelom zelllinie
BR0015872A (pt) Agentes antitrombóticos
EP1227159A4 (en) MONOCLONAL ANTIBODY, HYBRIDOMA, IMMUNITY TEST AND DIAGNOSTIC KIT
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
NO20022024D0 (no) Fremgangsmåte for å gjenta meldinger i lange intelligente kompletterings-systemlinjer
PL361803A1 (pl) Sposób zobojętniania popiołu, sztuczna pucolana otrzymana przy użyciu wymienionego sposobu
DE60136685D1 (de) Haarwuchsmittel
EP1556499A4 (en) FOR CARCINOGENIC BACTERIA SPECIFIC MONOCLONAL ANTIBODIES
NO20015285L (no) Fremstillingsprosess for n¶ringsmiddelfermenterende midler
DE10195796D2 (de) Brennstoffzellenanlage
ITPD20000192A0 (it) Anticorpi policlonali
EP1483292A4 (en) MONOCLONAL ANTIBODIES WITH CROSS-REACTION AGAINST BACTERIAL COLLAGEN BINDING PROTEINS
EE200300377A (et) Loomulikud HI-viiruse vastased antikehad
DE59913949D1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2
UA50030A (uk) Комплексне добриво
AR028262A1 (es) Anticuerpos especificos de fap-alfa humanos
ZA200200730B (en) Human monoclonal antibodies to prostate specific membrane antigen.
SK2912U (sk) Kombinované kogeneračné zariadenie
NO20002593D0 (no) Hjelpemiddel for ryggstrekk

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee